The PromptDegrader™ Platform
A First-in-Class platform for Targeted Protein Degradation of intrinsically disordered regions of proteins to balance protein homeostasis in oncology, neurology, innate and adaptive immune response, virology and ageing.
(Full website under construction)
The targeted therapy company
At RDP Pharma, we identify and acquire new therapeutic modalities to create breakthrough medicines poised to be game-changing life science technologies that are at an innovation inflexion point:
“When the technology is about to move from ‘great science’ to ‘great impact’ for patients and healthcare systems”.
We aim is to rapidly develop these technologies, through deep expertise, to key value inflexion points where the value to a patient population is demonstrated.